336 related articles for article (PubMed ID: 20660697)
1. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
Stepanova M; Rafiq N; Younossi ZM
Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
[TBL] [Abstract][Full Text] [Related]
2. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
Ong JP; Pitts A; Younossi ZM
J Hepatol; 2008 Oct; 49(4):608-12. PubMed ID: 18682312
[TBL] [Abstract][Full Text] [Related]
3. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.
Bell BP; Manos MM; Zaman A; Terrault N; Thomas A; Navarro VJ; Dhotre KB; Murphy RC; Van Ness GR; Stabach N; Robert ME; Bower WA; Bialek SR; Sofair AN
Am J Gastroenterol; 2008 Nov; 103(11):2727-36; quiz 2737. PubMed ID: 18684170
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of fibrosis in patients with chronic liver disease.
Stepanova M; Aquino R; Alsheddi A; Gupta R; Fang Y; Younossi Z
Aliment Pharmacol Ther; 2010 May; 31(10):1085-94. PubMed ID: 20175770
[TBL] [Abstract][Full Text] [Related]
6. Association of chronic liver disease with depression: a population-based study.
Lee K; Otgonsuren M; Younoszai Z; Mir HM; Younossi ZM
Psychosomatics; 2013; 54(1):52-9. PubMed ID: 23295007
[TBL] [Abstract][Full Text] [Related]
7. Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C.
Younossi ZM; Zheng L; Stepanova M; Venkatesan C; Mir HM
Aliment Pharmacol Ther; 2013 Apr; 37(7):703-9. PubMed ID: 23432436
[TBL] [Abstract][Full Text] [Related]
8. Past exposure to hepatitis B: a risk factor for increase in mortality?
Jinjuvadia R; Liangpunsakul S; Antaki F
J Clin Gastroenterol; 2014 Mar; 48(3):267-71. PubMed ID: 23751854
[TBL] [Abstract][Full Text] [Related]
9. Caffeine is protective in patients with non-alcoholic fatty liver disease.
Birerdinc A; Stepanova M; Pawloski L; Younossi ZM
Aliment Pharmacol Ther; 2012 Jan; 35(1):76-82. PubMed ID: 22059453
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.
Tsochatzis EA; Manolakopoulos S; Papatheodoridis GV; Archimandritis AJ
Scand J Gastroenterol; 2009; 44(1):6-14. PubMed ID: 18661429
[TBL] [Abstract][Full Text] [Related]
11. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
[TBL] [Abstract][Full Text] [Related]
12. Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population.
Younossi ZM; Stepanova M
Hepatology; 2011 Oct; 54(4):1167-78. PubMed ID: 21725988
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
[TBL] [Abstract][Full Text] [Related]
14. Mortality associated with alcohol-related liver disease.
Trimble G; Zheng L; Mishra A; Kalwaney S; Mir HM; Younossi ZM
Aliment Pharmacol Ther; 2013 Sep; 38(6):596-602. PubMed ID: 23889765
[TBL] [Abstract][Full Text] [Related]
15. Risk and predictors of mortality associated with chronic hepatitis B infection.
Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844
[TBL] [Abstract][Full Text] [Related]
16. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.
Golabi P; Paik JM; Eberly K; de Avila L; Alqahtani SA; Younossi ZM
Ann Hepatol; 2022; 27(1):100556. PubMed ID: 34800721
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
Miele L; Vallone S; Cefalo C; La Torre G; Di Stasi C; Vecchio FM; D'Agostino M; Gabrieli ML; Vero V; Biolato M; Pompili M; Gasbarrini G; Rapaccini G; Amerio P; De Simone C; Grieco A
J Hepatol; 2009 Oct; 51(4):778-86. PubMed ID: 19664838
[TBL] [Abstract][Full Text] [Related]
18. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents.
Graham RC; Burke A; Stettler N
J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):442-9. PubMed ID: 19644391
[TBL] [Abstract][Full Text] [Related]
19. Chronic liver disease mortality in the United States, 1990-1998.
Vong S; Bell BP
Hepatology; 2004 Feb; 39(2):476-83. PubMed ID: 14768001
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
Muntner P; He J; Chen J; Fonseca V; Whelton PK
Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
